These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26619140)

  • 1. Can we design drugs for HIV/AIDS that are less susceptible to resistance?
    Weber IT
    Future Med Chem; 2015; 7(17):2301-4. PubMed ID: 26619140
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential of 4'-C-substituted nucleosides for the treatment of HIV-1.
    Hayakawa H; Kohgo S; Kitano K; Ashida N; Kodama E; Mitsuya H; Ohrui H
    Antivir Chem Chemother; 2004 Jul; 15(4):169-87. PubMed ID: 15457679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic testing in clinical practice.
    Holodniy M
    AIDS Patient Care STDS; 1998 Jul; 12(7):527-31. PubMed ID: 15462003
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical research of HIV-1 resistance in three AIDS patients who had experienced multiple regimens.
    Lu JF; Li J; Li HP; Liu SY; Zhuang DM; Liu YJ; Bao ZY; Li L; Wu H; Li JY
    Chin Med J (Engl); 2009 Mar; 122(6):752-4. PubMed ID: 19323948
    [No Abstract]   [Full Text] [Related]  

  • 5. Rational approach to AIDS drug design through structural biology.
    Wlodawer A
    Annu Rev Med; 2002; 53():595-614. PubMed ID: 11818491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV drug resistance and laboratory methods for its detection (Lecture)].
    Bobkova MR
    Klin Lab Diagn; 2002 Jan; (1):25-32. PubMed ID: 11855336
    [No Abstract]   [Full Text] [Related]  

  • 7. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.
    Pillay D
    Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance.
    Re MC; Bon I; Monari P; Gorini R; Schiavone P; Gibellini D; La Placa M
    New Microbiol; 2003 Oct; 26(4):405-13. PubMed ID: 14596353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses.
    Schinazi RF; Hernandez-Santiago BI; Hurwitz SJ
    Antiviral Res; 2006 Sep; 71(2-3):322-34. PubMed ID: 16716415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevalence of HIV-1 drug resistance and associated factors in AIDS patients receiving HAART in Zhecheng county, Henan province].
    Yuan Y; Xing H; Wang XY; Liu CH; Yang LT; Zheng BF; Wang X; Ruan YH; Wang Z; Liu HW; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):619-24. PubMed ID: 22041566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern methods of detection of HIV resistance to the action of anti-retroviral agents].
    Bobkova MR
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):90-100. PubMed ID: 11871314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy.
    Venturi G; Romano L; Carli T; Corsi P; Pippi L; Valensin PE; Zazzi M
    Antivir Ther; 2002 Dec; 7(4):245-50. PubMed ID: 12553478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for structure-guided design of AIDS antivirals.
    Blundell TL
    Prog Biophys Mol Biol; 2005 Jun; 88(2):191-2. PubMed ID: 15572154
    [No Abstract]   [Full Text] [Related]  

  • 15. Discordance between genotypic resistance and pseudovirus phenotypic resistance in AIDS patients after long-term antiretroviral therapy and virological failure.
    Yang J; Geng W; Zhang M; Han X; Shang H
    J Basic Microbiol; 2014 Oct; 54(10):1120-5. PubMed ID: 24338739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 drug resistance among untreated patients in India: Current status.
    Pachamuthu B; Shanmugam S; Nagalingeswaran K; Solomon SS; Solomon S; Solomon S
    J Postgrad Med; 2006; 52(3):183-6. PubMed ID: 16855318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance mutations in HIV type 1 isolates from naive patients eligible for first line antiretroviral therapy in JJ Hospital, Mumbai, India.
    Deshpande A; Karki S; Recordon-Pinson P; Fleury HJ
    AIDS Res Hum Retroviruses; 2011 Dec; 27(12):1345-7. PubMed ID: 21453163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
    Li J; Jiao LY; Li HP; Li L; Liu YJ; Zhuang DM; Liu SY; Bao ZY; Li H; Wang Z; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 reverse transcriptase inhibitors.
    El Safadi Y; Vivet-Boudou V; Marquet R
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the correlation between HIV drug resistance and CD4+ T-lymphocyte of AIDS patients under antiretroviral treatment in Henan province].
    Zhu XP; Li H; Liu HW; Yuan Y; Liu CH; Zhu Q; Cui WG; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1181-4. PubMed ID: 19173959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.